Iodide

Iodide

SCHEMBL5086696

CCCCCCCCCCCCCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.56
CHRNA7 P36544 9/20 0.49
TRAP1 Q12931 2/20 0.46
ALDH1A1 P00352 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
CSNK1E P49674 1/20 0.41
DNM1 Q05193 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL298493 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5085194 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL2505241 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL10684637 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL3859955 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL6904643 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Decyltriphenylphosphonium SCHEMBL3654788 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5085133 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL2354963 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2
Iodide SCHEMBL5091833 1.00 HIF1A (0.56) HIF1ACHRNA7TRAP1ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2823709-A1 The use of ionic salts containing phosphonium cation Akademia im. Jana Dlugosza (PL) 2015-01-14 EP claimed
EP-3124027-A1 TRIPHENYLPHOSPHONIUM SALTS FOR USE IN CANCER THREAPY Centrum Badan Molekularnych I Makromolekularnych Polskiej Akademii Nauk (PL) 2017-02-01 EP disclosed
EP-2823709-A1 The use of ionic salts containing phosphonium cation Akademia im. Jana Dlugosza (PL) 2015-01-14 EP disclosed
EP-2823709-A1 The use of ionic salts containing phosphonium cation Akademia im. Jana Dlugosza (PL) 2015-01-14 EP disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed
US-5591874-A ISOMERIZATION OF VINYL ETHYLENE CARBONATE COMPOUND USING CATALYST SYSTEM COMPRISING ACIDIC AND HALOGEN COMPONENTS EASTMAN CHEMICAL COMPANY (US) 1997-01-07 US disclosed